Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice.

Donroe JH, Holt SR, O'Connor PG, Sukumar N, Tetrault JM.

Drug Alcohol Depend. 2017 Nov 1;180:46-51. doi: 10.1016/j.drugalcdep.2017.07.040. Epub 2017 Aug 24.

PMID:
28866369
2.

High prevalence of urine tampering in an office-based opioid treatment practice detected by evaluating the norbuprenorphine to buprenorphine ratio.

Accurso AJ, Lee JD, McNeely J.

J Subst Abuse Treat. 2017 Dec;83:62-67. doi: 10.1016/j.jsat.2017.10.002. Epub 2017 Oct 12.

PMID:
29129197
3.

Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment.

Suzuki J, Zinser J, Issa M, Rodriguez C.

Subst Abus. 2017 Oct-Dec;38(4):504-507. doi: 10.1080/08897077.2017.1356796. Epub 2017 Jul 19.

PMID:
28723256
4.

Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder.

Holt SR, Donroe JH, Cavallo DA, Tetrault JM.

Drug Alcohol Depend. 2018 May 1;186:171-174. doi: 10.1016/j.drugalcdep.2017.12.040. Epub 2018 Mar 2. Erratum in: Drug Alcohol Depend. 2019 Dec 1;205:107601.

PMID:
29579725
5.

Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.

Concheiro M, Shakleya DM, Huestis MA.

Forensic Sci Int. 2009 Jul 1;188(1-3):144-51. doi: 10.1016/j.forsciint.2009.04.005. Epub 2009 Apr 29.

6.

Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine
.

Strang J, Knight A, Baillie S, Reed K, Bogdanowicz K, Bell J.

Int J Clin Pharmacol Ther. 2018 Feb;56(2):81-85. doi: 10.5414/CP203118.

PMID:
29231163
7.

Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry.

McMillin GA, Davis R, Carlisle H, Clark C, Marin SJ, Moody DE.

J Anal Toxicol. 2012 Mar;36(2):81-7. doi: 10.1093/jat/bkr020.

PMID:
22337776
8.

Urine is superior to oral fluid for detecting buprenorphine compliance in patients undergoing treatment for opioid addiction.

Ransohoff JR, Petrides AK, Piscitello GJ, Flood JG, Melanson SEF.

Drug Alcohol Depend. 2019 Oct 1;203:8-12. doi: 10.1016/j.drugalcdep.2019.06.015. Epub 2019 Aug 1.

PMID:
31394416
9.

Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.

Marin SJ, McMillin GA.

Methods Mol Biol. 2016;1383:69-78. doi: 10.1007/978-1-4939-3252-8_8.

PMID:
26660175
10.

Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.

Huang P, Kehner GB, Cowan A, Liu-Chen LY.

J Pharmacol Exp Ther. 2001 May;297(2):688-95.

PMID:
11303059
11.
12.

Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment.

Kacinko SL, Jones HE, Johnson RE, Choo RE, Concheiro-Guisan M, Huestis MA.

Clin Chem. 2009 Jun;55(6):1177-87. doi: 10.1373/clinchem.2008.113712. Epub 2009 Mar 26.

13.

Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry.

Vincent F, Bessard J, Vacheron J, Mallaret M, Bessard G.

J Anal Toxicol. 1999 Jul-Aug;23(4):270-9.

PMID:
10445490
14.

Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.

Tzatzarakis MN, Vakonaki E, Kovatsi L, Belivanis S, Mantsi M, Alegakis A, Liesivuori J, Tsatsakis AM.

J Anal Toxicol. 2015 May;39(4):313-20. doi: 10.1093/jat/bkv003. Epub 2015 Feb 7.

PMID:
25663675
15.

HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples.

Tracqui A, Kintz P, Mangin P.

J Forensic Sci. 1997 Jan;42(1):111-4.

PMID:
8988582
16.

LC-MS-MS analysis of buprenorphine and norbuprenorphine in whole blood from suspected drug users.

Seldén T, Roman M, Druid H, Kronstrand R.

Forensic Sci Int. 2011 Jun 15;209(1-3):113-9. doi: 10.1016/j.forsciint.2011.01.011. Epub 2011 Feb 8.

PMID:
21306845
17.

Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.

Concheiro-Guisan M, Shakleya DM, Huestis MA.

Anal Bioanal Chem. 2009 May;394(2):513-22. doi: 10.1007/s00216-009-2706-z. Epub 2009 Feb 27.

18.

Quantitation of Total Buprenorphine and Norbuprenorphine in Meconium by LC-MS/MS.

Marin SJ, McMillin GA.

Methods Mol Biol. 2016;1383:59-68. doi: 10.1007/978-1-4939-3252-8_7.

PMID:
26660174
19.

Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration.

Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder JR, Jasinski DR, Johnson RE, Jones HE, Huestis MA.

Clin Chem. 2007 Dec;53(12):2136-43. Epub 2007 Oct 5.

20.

Supplemental Content

Support Center